Navigation Links
Spirit of ovarian cancer advocate keeps fundraising drive on track

PHOENIX, Ariz. April 20, 2010 The Anne Rita Monahan Foundation recently presented $15,000 for ovarian cancer research to the Translational Genomics Research Institute (TGen).

That amount brings to $50,000 the total amount raised by the organization named for Anne Rita Monahan, a Phoenix woman who used her initials to encourage women to "ARM yourself against ovarian cancer."

Funds were raised at the 2nd annual Tea for TEAL, the color associated with ovarian cancer. The English-style tea for 160 people was held Feb. 2 at the Sheraton Phoenix Downtown Hotel, the first time the event was held after Monahan lost her battle to ovarian cancer in May. She was 47.

"I still felt her presence there," said Richard Corley, Treasurer of the ARM Foundation and a life-long friend of Monahan. "It was very sad for her not to grace the event. She had such a personality. Everyone would have wanted to hear what she had to say."

Monahan started her foundation in 2007, six years after she was diagnosed with ovarian cancer, with the mission to eradicate this disease. Her foundation has continued her efforts to make woman aware of the signs and symptoms of ovarian cancer, to encourage early detection, minimize misdiagnosis and fund research into developing evidence-based rationales for precision therapy and a reliable screening test.

A 3rd annual Tea for TEAL is planned next spring, perhaps closer to Mother's Day, said Rachel Busch, President of the ARM Foundation. "I'd like to see us continue with Anne's dream."

That includes eventually reaching Monahan's fundraising goal of $100,000 for TGen's ovarian cancer research.

Dr. Heather Cunliffe, Head of TGen's Breast and Ovarian Cancer Research Unit, said the ARM Foundation has enabled TGen to work with two hospitals with two additional sites approved for launch shortly to consent ovarian cancer patients to donate excess tissues to facilitate TGen's research effort.

"We have Anne's photos all over our lab," Dr. Cunliffe said. "She is really an inspiration, and her personal story empowers us to find a solution as fast as possible. Anne's determination and passion to eradicate ovarian cancer intensifies our efforts."

TGen launched a prospective biospecimen acquisition protocol in June 2009 with the aim of collecting 100 ovarian tumors for research. Biospecimens are preserved following strict procedures designed by Dr. Cunliffe's lab to facilitate state-of-the-art genomic characterization of ovarian cancer. Outcomes anticipated include advanced diagnostic and predictive measures to guide optimal treatment decisions.

"This is a highly heterogeneous and complex disease," Dr. Cunliffe said. "The technology we have available today is ideally suited to solving the severe problem of drug-resistant ovarian cancer. A significant additional benefit will be identification of more robust diagnostic biomarkers for the earlier detection of disease onset".

"Anne would be so proud of that," Corley said. "Thirteen women fighting ovarian cancer today are allowing TGen to make discoveries that will benefit women newly diagnosed with ovarian cancer all because of the work that she started."

Michael Bassoff, President of the TGen Foundation, said funds from the ARM Foundation are making a significant difference in advancing research into ovarian cancer. "We are honored to be carrying on the work inspired by Anne Rita Monahan. Her legacy will be earlier diagnostics and smarter treatments for patients with this devastating disease."

Monahan was an honors graduate of Boston College in Business Administration, earned a Masters of Business Administration at Arizona State University, and retired as a small-business counselor with Maricopa County.


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. Smells like bees spirit
2. The pill for ovarian cysts
3. Dietary factors influence ovarian cancer survival rates
4. Disarming specialized stem cells might combat deadly ovarian cancer
5. Assessing lead time of selected ovarian cancer biomarkers
6. FDA approved leukemia drugs shows promise in ovarian cancer cells
7. Nanoparticle-delivered suicide genes slowed ovarian tumor growth
8. 2 reproductive factors are important predictors of death from ovarian cancer
9. Genetic factors implicated in survival gap for breast, ovarian or prostate cancer
10. Ovarian transplantation: First baby is born after a new technique
11. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
Post Your Comments:
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... announced that Google has adopted the Synaptics ® ... solutions to power its newest flagship smartphones, the Nexus ... --> --> ... to provide strategic collaboration in the joint development of ...
(Date:10/26/2015)... , Oct. 26, 2015  Delta ID Inc., ... authentication to mobile and PC devices, announced its ActiveIRIS® ... the arrows NX F-02H launched by NTT DOCOMO, INC ... F-02H is the second smartphone to include iris recognition ... in ARROWS NX F-04G in May 2015, world,s first ...
(Date:10/22/2015)... AWRE ), a leading supplier of biometrics software and services, ... 2015.  --> --> Revenue ... of 33% compared to $6.0 million in the same quarter last ... million, or $0.10 per diluted share, which compared to $2.6 million, ... ago.  --> --> Lower ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
Breaking Biology Technology: